Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
ACE Report #12021
Ace Report Cover Trauma

OTA 2019: No difference in outcomes between AIBG and cement in tibial plateau fracture bone defects

Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Autologous Iliac Bone Graft versus Biphasic Hydroxyapatite/Calcium Sulfate Cement for Treatment of Bone Defects in Tibial Plateau Fractures: A Multicenter, Prospective, Randomized Clinical Trial

Contributing Authors: Alex Hofmann Stanislav Gorbulev Paul Alfred Grützner Arndt P Schulz Rupert Schupfner M Raschke M van Griensven PM Rommens

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.


Bone graft substitutes are generally required in tibial plateau fractures. Previous studies have established calcium phosphate as superior to autogenous iliac crest bone graft (AIBG), at least in terms of subsidence. The authors in this study randomized 137 patients with AO 41-B2 and 41-B3 fractures to receiver either AIBG or a hydroxyapatite/calcium sulfate cement. Outcomes measured were the SF-1...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.